EXAS vs PLUS · rev $2.76B vs P/E 17, rev $2.07B
EXACT Sciences Corporation (EXAS) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
EXAS currently screens at market cap $20.03B. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the EXAS and PLUS stock pages for the full models.
Not investment advice.